No Infringement by Other Persons. To the knowledge of the Company, no Company Owned Intellectual Property or Company Licensed Intellectual Property that is exclusively licensed to the Company has been infringed, misappropriated or violated by any Person.
No Infringement by Other Persons. To the Knowledge of Target, no Target Proprietary Rights owned by or exclusively licensed to Target have been infringed, misappropriated or impermissibly disclosed by any Person.
No Infringement by Other Persons. To the Knowledge of Target, (i) no Patents that are Target Owned Intellectual Property or Target Licensed Intellectual Property exclusively licensed to Target or any Subsidiary of Target have been infringed, misappropriated or violated by any Person and (ii) no Intellectual Property Rights other than Patents that are Target Owned Intellectual Property or Target Licensed Intellectual Property exclusively licensed to Target or any Subsidiary of Target have been infringed, misappropriated or violated by any Person.
No Infringement by Other Persons. To the Knowledge of Target, no Target Owned Intellectual Property has been infringed, misappropriated or violated by any Person.
No Infringement by Other Persons. To Seller’s Knowledge, no Acquired Proprietary Rights have been infringed or misappropriated by any Person. Since October 20, 2008, Seller has not brought or resolved any action, suit, claim or proceeding for infringement of any Acquired Proprietary Rights or breach of any license or other Contract involving the Acquired Proprietary Rights against any Person.
No Infringement by Other Persons. No Person has infringed, misappropriated or otherwise violated, and no Person is currently infringing, misappropriating or otherwise violating, any Company Owned Proprietary Right or, to the Company’s Knowledge, any Company Licensed Proprietary Right that is exclusively licensed to the Company. There is no unauthorized use, disclosure or misappropriation of the Company Proprietary Rights by any Person, including without limitation any [*] Confidential treatment requested. 49 CONFIDENTIAL TREATMENT REQUESTED current or former officer, manager, director, stockholder, member, employee, consultant or independent contractor of the Company or any Company Subsidiary. Section 2.14(e)(v) of the Disclosure Schedule accurately identifies in all material respects each written or electronic communication or correspondence that has been sent or otherwise delivered by or to any party to a Contract listed or required to be listed in Section 2.14(d) of the Disclosure Schedule, or any officers, directors, employees, partners, accountants, auditors, attorneys, advisors, representatives and other agents of any such other party to such a Contract, regarding any actual, alleged or suspected infringement or misappropriation of any Company Proprietary Right and provides a brief description of the current status of the matter referred to in such letter, communication or correspondence.
No Infringement by Other Persons. No Company Owned Intellectual Property or Company Licensed Intellectual Property that is exclusively licensed to Company, is being or has been infringed, misappropriated or violated by any Person, provided that the foregoing is qualified to the Company’s Knowledge with respect to Patents. The Company has not notified any Person (including any demand letter, unsolicited offer to license or any cease and desist letter) or made any assertions to any Person that such Person is infringing, misappropriating or violating any Company Owned Intellectual Property or any Company Licensed Intellectual Property that is exclusively licensed to Company.
No Infringement by Other Persons. No Person has infringed, misappropriated or otherwise violated, and no Person is currently infringing, misappropriating or otherwise violating, any Company Owned Proprietary Right included within the Aeroquin™ IP or, to the Company’s Knowledge, any Company Licensed Proprietary Right included within the Aeroquin™ IP that is exclusively licensed to the Company. There is no unauthorized use, disclosure or misappropriation of the Company Proprietary Rights included within the Aeroquin™ IP by any Person, including without limitation any current or former officer, manager, director, stockholder, member, employee, consultant or independent contractor of the Company or any Company Subsidiary. Section 4.9.13 of the Disclosure Schedule accurately identifies in all material respects each written or electronic communication or correspondence that has been sent or otherwise delivered by or to any party to a Contract listed or required to be listed in Sections 4.9.5-4.9.8 of the Disclosure Schedule, or any officers, directors, employees, partners, accountants, auditors, attorneys, advisors, representatives and other agents of any such other party to such a Contract, regarding any actual, alleged or suspected infringement or misappropriation of any Company Owned Proprietary Right included within the Aeroquin™ IP or, to the Company’s Knowledge, any Company Licensed Proprietary Right that is exclusively licensed to the Company and provides a brief description of the current status of the matter referred to in such letter, communication or correspondence.
No Infringement by Other Persons. To the Kita Shareholders’ knowledge, no Company Owned Intellectual Property has been infringed, misappropriated or violated by any Person.
No Infringement by Other Persons. Except as set forth in Section 3.13.5 of the Disclosure Schedules, to the Knowledge of Seller, no Seller Owned Intellectual Property or Seller Licensed Intellectual Property that is exclusively licensed to Seller is currently being, or since January 1, 2020 has, infringed, misappropriated or violated by any operation or conduct of any Person.
